U.S. Specialized REITs Stock News

NYSE:MP
NYSE:MPMetals and Mining

3 Rare Earth Stocks With Market Caps Over $989 Million

Growing concern over underwater cables and energy infrastructure security has pushed governments to rethink where critical materials come from. Rare earth miners sit right in that conversation because their output goes into advanced sensors, subsea monitoring gear, and defense systems. That link between security and supply is creating fresh attention on rare earth metal opportunities. This article highlights three rare earth stocks pulled from our specialist screener. The three rare earth...
NasdaqGM:SMMT
NasdaqGM:SMMTBiotechs

Summit Therapeutics (SMMT) Is Getting Fresh Attention, What Is Behind It?

Summit Therapeutics (SMMT) is back in focus after presenting updated Phase III HARMONi and HARMONi-2 data on ivonescimab at the IASLC World Conference on Lung Cancer, highlighting overall survival trends and safety consistency. Recent trading suggests momentum around Summit Therapeutics is building, with a 30-day share price return of 43.60% and a 90-day gain of 29.82%, while the 1-year total shareholder return is still down 5.51%. The very large 3-year total shareholder return hints at how...
NasdaqGS:ALGN
NasdaqGS:ALGNMedical Equipment

How Investors May Respond To Align Technology (ALGN) Lower Revenue Guidance

Align Technology recently presented at the 2026 Global Healthcare Conference in New York, with CFO John F. Morici and IR lead Madelyn Valente outlining the company’s position after reporting quarterly earnings that exceeded expectations but came with lowered Q3 revenue guidance. The combination of better reported results and a more cautious revenue outlook highlights how inflation and postponed elective dental treatments remain a real drag on near term demand for Align’s clear aligners and...
NYSE:JOBY
NYSE:JOBYAirlines

How Autonomous Cross Country Flight At Joby Aviation (JOBY) Has Changed Its Investment Story

Joby Aviation reported that its J208 aircraft, a converted Cessna Caravan, completed a 3,199 mile, fully autonomous U.S. cross country flight under remote supervision, handling taxi, takeoff, routing, and landings across varied airports and weather conditions. The cross country tour shows how Joby can apply its autonomy stack to already certified airframes for freight, medical logistics, disaster response, and defense work, which directly links expensive R&D to potential real world contracts...
NYSE:SNA
NYSE:SNAMachinery

3 High Quality Dividend Stocks For Steady Income As Rates Stay Higher

Interest rates are climbing again, inflation is stubborn, and headline stock indexes have been restless since mid August, which puts steady cash returns back in the spotlight for many investors. Reliable dividends can feel like solid ground when borrowing costs rise and growth stories come under pressure. This article walks through 3 dividend-focused stocks exposed to these macro shifts and explains how each one could factor into your portfolio decisions now. The stocks highlighted below are...
NYSE:UNP
NYSE:UNPTransportation

Conference Update Could Be A Big Moment For Union Pacific Stock

Union Pacific executives recently outlined volume trends, fuel cost pressures, and network investment priorities at Morgan Stanley's Laguna Conference, while the Big Boy No. 4014 holiday tour supports Make-A-Wish through the Community Ties Giving Program. The focus on high-growth freight segments like renewable fuels and automotive gives investors a clearer view of where Union Pacific is targeting future volume opportunities. We will now see how Union Pacific's focus on high-growth freight...
NYSE:HWM
NYSE:HWMAerospace & Defense

Howmet Aerospace (HWM) Could Be 39% Undervalued On Raised 2026 Guidance

Howmet Aerospace (HWM) raised its 2026 revenue and adjusted EBITDA guidance after stronger defense aerospace activity, including higher defense revenues in 2025 and 2026 and new work tied to drones and collaborative combat aircraft programs. That raised guidance comes after a choppy few months for Howmet Aerospace, with the share price down about 19% over the past 30 days and 17% over the last quarter, even as the stock shows an 8.5% year to date share price return and a 1 year total...
NasdaqGS:CGNX
NasdaqGS:CGNXElectronic

Cognex (CGNX) Rallies On A 23% Undervalued View, Is The Premium P E Too Rich?

Without a clear single event driving headlines, Cognex (CGNX) is drawing attention for its recent share performance and fundamentals, which together provide investors with fresh data points to reassess expectations. At around US$61.56, Cognex has delivered a 66.69% year to date share price return. However, the 7 day share price move is down 4.14%, which hints that momentum has cooled, even as the 1 year total shareholder return of 33.30% keeps the longer view positive. Scan how Cognex fits...
NasdaqGS:DLTR
NasdaqGS:DLTRConsumer Retailing

Multi Price Gains Might Change The Case For Investing In Dollar Tree Stock (DLTR)

Dollar Tree has shifted permanently to a multi price model, with products now offered at tiers like $3, $5, and up to $7, and recent results show 7.0% sales growth alongside a 3.3% larger average ticket. This move broadens Dollar Tree’s product range and mix, but it also forces budget focused shoppers to watch price labels more carefully to avoid surprises at checkout. We will explore how Dollar Tree's confirmed traction with its higher multi price tiers could reshape the longer term...
NYSE:CNP
NYSE:CNPIntegrated Utilities

Credit Facility Refresh Could Be A Game Changer For CenterPoint Energy Stock (CNP)

CenterPoint Energy replaced its prior US$2.40b unsecured revolving credit facility with a new five-year US$2.20b senior unsecured facility that includes swingline and letter of credit features, as well as temporary leverage flexibility tied to disaster recovery spending. The new covenant allowing a higher debt to capitalization ratio during large natural disaster restorations offers CenterPoint Energy added room to fund infrastructure repairs without immediately pressuring balance sheet...
NYSE:LUV
NYSE:LUVAirlines

Southwest Airlines (LUV) Following Redburn Upgrade, Is The Premium Push Still Undervalued?

Southwest Airlines (LUV) is back in focus after Redburn shifted its rating from Sell to Neutral, while the carrier pushes into higher-margin offerings such as airport lounges and new premium products. That shift in story is arriving against a mixed tape for Southwest Airlines, with the share price at US$40.98 after a 1-day share price return of 1.59% and a 7-day share price return of 4.43%. At the same time, the 90-day share price return has declined 14.57%, and the 5-year total shareholder...
NasdaqGS:PPC
NasdaqGS:PPCFood

Ready Meals Partnership Could Matter For Pilgrim's Pride Stock (PPC)

Pilgrim's Pride, through Pilgrim’s Europe Finance PLC, issued €500 million of 4.75% senior notes due 2034 and is partnering with Associated British Foods to produce Asian-inspired ready meals in the UK under the Patak’s and Blue Dragon brands. The tie-up with Associated British Foods positions Pilgrim's Pride to use its large Carrickmacross frozen meals facility to deepen its exposure to higher value prepared foods in Europe. We will now look at how Pilgrim's Pride's investment narrative...
NYSE:ALB
NYSE:ALBChemicals

Will Fair Value Cut Change Albemarle Stock Narrative

Albemarle is preparing to report earnings and revenue that analysts expect to be significantly higher than a year ago, while the firm continues to push lithium conversion capacity projects and operational efficiencies in a period of choppy lithium pricing. The downward revision of Albemarle’s fair value estimate, tied to lithium market volatility and regulatory risk, highlights how cost discipline, long term contracts and productivity gains are being weighed against a more cautious sector...
NYSE:RNG
NYSE:RNGSoftware

RingCentral (RNG) Shares Moved, What Is Behind The Attention Now?

RingCentral (RNG) is pushing deeper into AI with a new ChatGPT plugin and MCP connectors for Claude, designed to feed live voice, SMS, and chat data directly into large language models. Against that product backdrop, RingCentral’s share price tells a story of rebuilding confidence. The stock is up 8.98% over 30 days and has a 90 day share price return of 105.20%, while the 1 year total shareholder return of 131.41% contrasts with a 5 year total shareholder return that remains down...
NYSE:SFBS
NYSE:SFBSBanks

Why ServisFirst Bancshares (SFBS) Is Getting Fresh Attention

Recent analysis of ServisFirst Bancshares (SFBS) has focused on accelerating annualized revenue growth, a meaningfully wider net interest margin, and steady earnings per share gains over five years as key drivers of fresh investor attention. ServisFirst Bancshares' share price has eased over the past month, with a 1-month share price return of down 5.56%, even though the year-to-date share price return is up 15.43% and the 3-year total shareholder return of 76.90% points to momentum that has...
NYSE:FUL
NYSE:FULChemicals

H.B. Fuller (FUL) Could Be 33% Undervalued Following Earnings Expectations

Earnings expectations put H.B. Fuller in focus Wall Street projections for H.B. Fuller (FUL) are drawing fresh attention. Analysts expect quarterly earnings of $1.46 per share and revenue of $940.38 million for the August 2026 period. H.B. Fuller shares have come under pressure recently, with the 30-day share price return down 18.8% and the 90-day move down 23.8%. The 1-year total shareholder return has declined 17.4%, hinting that enthusiasm is fading even as the recent sustainability...
NYSE:AVNT
NYSE:AVNTChemicals

Avient (AVNT) Could Be 12% Undervalued As Mix Limits Near Term Growth

Avient (AVNT) has come into focus after recent trading saw the share price close at $40.36, with short term returns under pressure even as the year-to-date move remains positive. Recent trading in Avient reflects that pattern. The share price has eased over the past week and month; however, the 90 day share price return of 7.17% and year to date share price gain of 27.28% sit alongside a 1 year total shareholder return of 18.46%. This suggests that longer term momentum has been stronger than...
NasdaqGS:AVT
NasdaqGS:AVTElectronic

Earnings Beat Might Change The Case For Investing In Avnet Stock (AVT)

Avnet has attracted fresh attention after solid quarterly results, expanding digital infrastructure and e-commerce investments at Farnell, and deeper exposure to cloud, AI, and industrial automation customers. The new EMUS Lab collaboration with The University of Hong Kong gives Avnet direct visibility into early AI hardware projects and real-world commercialization hurdles. This article examines how Avnet's investment narrative is shaped by its AI hardware collaboration and broader digital...
NYSE:MAC
NYSE:MACRetail REITs

Macerich (MAC) Sees Fresh Leasing Momentum, Is The Stock Cheap?

Macerich (MAC) is back in focus after management appeared at the BofA NY Global Real Estate Conference, outlining fresh leasing momentum, consumer traffic trends, and plans for new store commitments across its mall portfolio. Recent action around Macerich reflects this story playing out in real time. The share price has risen 22.19% year to date and the 1-year total shareholder return is 34.05%, while a 30-day share price return of down 9.12% suggests enthusiasm has cooled even as the 3-year...
NasdaqGM:RYTM
NasdaqGM:RYTMBiotechs

Is Rhythm Pharmaceuticals (RYTM) Undervalued On Fresh Setmelanotide Data?

Rhythm Pharmaceuticals (RYTM) is back in focus after new clinical data on setmelanotide were shared at the European Society for Paediatric Endocrinology meeting, highlighting outcomes in children with rare hypothalamic obesity. Rhythm Pharmaceuticals’ recent clinical updates come at a more challenging time for the shares, which have fallen 15.6% on a 30-day share price return and 6.9% on a year-to-date basis. However, the 1-year total shareholder return is slightly positive and the 3-year...
NasdaqGM:AXSM
NasdaqGM:AXSMPharmaceuticals

Axsome Therapeutics (AXSM) Presents Fresh Psych Congress Data, Is The Stock Cheap?

Psych Congress data puts Axsome Therapeutics (AXSM) pipeline in focus Axsome Therapeutics (AXSM) drew fresh attention after presenting new data in major depressive disorder and Alzheimer’s disease agitation at Psych Congress 2026, alongside multiple encore posters across its psychiatry and neurology programs. Recent trading has been choppy for Axsome Therapeutics, with the share price down 3.03% over the past day and 17.05% over 90 days. However, the year-to-date share price return of 16.28%...
NYSE:CL
NYSE:CLHousehold Products

Colgate-Palmolive (CL) Could Be 31% Undervalued As Dividend Confidence Meets North America Fix

Colgate-Palmolive (CL) just reaffirmed its quarterly cash dividend at $0.53 per share, extending a dividend streak that dates back to 1895, as management works to revive a softer North America business. The share price reaction has been muted around the dividend news, with Colgate-Palmolive slipping 0.3% over the last session and easing 3.7% over 30 days. The stock has still posted a 12.6% year to date share price gain and a 10.5% 1 year total shareholder return, which suggests momentum has...
NasdaqGS:ABCL
NasdaqGS:ABCLLife Sciences

Why AbCellera Biologics (ABCL) Is Back In The Spotlight

Why AbCellera Biologics Stock Is Back In Focus AbCellera Biologics (ABCL) has drawn fresh attention after announcing an upcoming oral presentation of Phase 2 data for its investigational menopause drug ABCL635 at the International Menopause Society congress. The treatment targets moderate to severe vasomotor symptoms such as hot flashes, an area with a large patient population and meaningful unmet need, which helps explain why traders are watching the shares ahead of the data update. The...
NYSE:DRI
NYSE:DRIHospitality

Darden Restaurants (DRI) Could Be 10% Undervalued Following Its Recent Pullback

Darden Restaurants (DRI) heads into its first quarter fiscal 2027 earnings report on September 24, with investors focused on revenue trends, guidance, and recent share price weakness over the past month. Darden Restaurants shares have softened recently, with a 1-month share price return of down 5.68% and a 90-day move of down 1.95%. At the same time, the year-to-date share price return sits at 11.79% and the 1-year total shareholder return is 16.88%, suggesting that short term momentum has...